NEW HAVEN, Conn., June 08, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has launched the HemeScreen® Anemia Panel as part of its suite of ...

(AP) -- Federal health advisers say patients with failing kidneys should continue taking a group of widely used anemia drugs, despite a recent study showing they can increase the risk of stroke. A ...

WASHINGTON (Reuters) - U.S. health officials will ask an advisory panel whether they should withdraw the approval of Amgen Inc and Johnson & Johnson anemia drugs for cancer chemotherapy patients or ...

Kidney patients who aren't on dialysis should still get their anemia-drug treatments, an FDA advisory panel says. After discussing new safety data on Amgen's high-tech anemia treatment Aranesp, the ...

BALTIMORE, Maryland (Reuters) - Use of controversial anemia drugs made by Amgen Inc and Johnson & Johnson at high levels likely worsen heart problems and possibly chances for survival in kidney ...

A new drug from Affymax Inc to be used to treat anemia in patients with chronic kidney disease who are on dialysis has won the FDA panel approval. A Food and Drug Administration advisory panel voted ...

Should Amgen and Johnson & Johnson be worried? Medicare is convening a group of experts for advice on using the companies' blockbuster anemia drugs. The Centers for Medicare & Medicaid Services wants ...